2013
DOI: 10.1016/j.acuroe.2012.11.015
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of female stress urinary incontinence using suburethral slings: comparative, retrospective, observational study of two surgical techniques

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

1
2
0

Year Published

2015
2015
2016
2016

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 13 publications
1
2
0
Order By: Relevance
“…The hospital stay is a relevant factor in the cost difference, which is why that variable was analyzed in depth. On one hand, the duration obtained in our study is in accordance with other practices in our country, as is shown in the recent study from Castroviejo-Royo et al, 18 who indicated a stay of 3.83±2.46 days in patients treated using TVT-TOT. Girvent et al 19 analyzed interventions with TVT-O, obtaining an average stay of 2.7 days, equal to what was reported by others, such as Úbeda et al 20 or Álvarez Cañadas et al 21 A slightly shorter stay was described by Navazo et al 22 (1.5 days, range: 1-5) or Zullo et al 23 (1, 1±0.3 days).…”
Section: Discussionsupporting
confidence: 76%
“…The hospital stay is a relevant factor in the cost difference, which is why that variable was analyzed in depth. On one hand, the duration obtained in our study is in accordance with other practices in our country, as is shown in the recent study from Castroviejo-Royo et al, 18 who indicated a stay of 3.83±2.46 days in patients treated using TVT-TOT. Girvent et al 19 analyzed interventions with TVT-O, obtaining an average stay of 2.7 days, equal to what was reported by others, such as Úbeda et al 20 or Álvarez Cañadas et al 21 A slightly shorter stay was described by Navazo et al 22 (1.5 days, range: 1-5) or Zullo et al 23 (1, 1±0.3 days).…”
Section: Discussionsupporting
confidence: 76%
“…Castroviejo‐Royo et al reported superiority of Monarc™ compared to MiniArc™, with a cure rate of 84% vs. 72%.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, the MiniArc TM were associated with a higher rate of persistent SUI (34% vs. 9%). 20 Castroviejo-Royo et al 21 reported superiority of Monarc TM compared to MiniArc TM , with a cure rate of 84% vs. 72%.…”
Section: Discussionmentioning
confidence: 99%